Company Filing History:
Years Active: 2014
Title: Isabelle Cremer: Innovator in Cancer Treatment Prediction
Introduction
Isabelle Cremer is a prominent inventor based in Paris, France. She has made significant contributions to the field of cancer treatment through her innovative research and patented methods. Her work focuses on predicting patient responses to anti-cancer treatments, which is crucial for personalized medicine.
Latest Patents
Isabelle Cremer holds a patent titled "Methods for predicting the response to anti-cancer treatment with an agonist of TLR7 or an agonist of TLR8." This invention relates to methods for predicting the response to treatment with an agonist of TLR7, or an agonist of TLR8, or an anti-cancer agent for treating cancer, particularly non-small cell lung cancer. The method involves detecting the expression of TLR7 or TLR8 in cancer cells of the patient, which can help tailor treatment strategies effectively. She has 1 patent to her name.
Career Highlights
Isabelle Cremer is affiliated with the Institut National de la Santé et de la Recherche Médicale, where she conducts her research. Her work has been instrumental in advancing the understanding of cancer treatment responses, making her a valuable asset in the medical research community.
Collaborations
Isabelle collaborates with notable colleagues, including Julien Cherfils and Herve Fridman. Their combined expertise enhances the research efforts in cancer treatment and prediction methodologies.
Conclusion
Isabelle Cremer's innovative work in predicting responses to cancer treatments marks her as a key figure in the field of medical research. Her contributions are paving the way for more effective and personalized cancer therapies.